Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...
The "Thematic Intelligence: Rare Disease" report has been added to ResearchAndMarkets.com's offering.In recent years, there has been growing recognition of the importance of rare diseases as a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback